In another study, tumor cell CD248 expression was seen in 89% of undifferentiated pleomorphic sarcoma (104/117), 77% adult fibrosarcoma/spindle cell sarcoma (20/26), 62% synovial sarcoma (37/60), 51% leiomyosarcoma (94/185) and 31% rhabdomyosarcoma (39/126) [75]. This evidence concerns the gene CD248 and fibrosarcoma.